Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review Lauro Fabián Amador-Medina; Erick Crespo-Solís; Francisco Javier Turrubiates-Hernández; Karla Edith Santibañez-Bedolla;

Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy Lorena Lobo de Figueiredo-Pontes; Luiz Fernando Bazzo Catto; Maria de Lourdes Lopes Ferrari Chauffaille; Katia Borgia Barbosa Pagnano; Maria Isabel Ayrosa Madeira; Elenaide Coutinho Nunes; Nelson Hamerschlak; Marcela Cavalcante de Andrade Silva; Thiago Xavier Carneiro; Teresa Cristina Bortolheiro; Tiago Thalles de Freitas; Rosane Isabel Bittencourt; Evandro Maranhão Fagundes; Eduardo Magalhães Rego;

A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia Brunno Gilberto Santos de Macedo; Manuela Albuquerque de Melo; Diego Antonio Pereira-Martins; João Agostinho Machado-Neto; Fabiola Traina;